1. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. Issue 9 (November 2020) Authors: Faiena, Izak; Comin-Anduix, Begoña; Berent-Maoz, Beata; Bot, Adrian; Zomorodian, Nazy; Sachdeva, Ankush; Said, Jonathan; Cheung-Lau, Gardenia; Pang, Jia; Macabali, Mignonette; Chodon, Thinle; Wang, Xiaoyan; Cabrera, Paula; Kaplan-Lefko, Paula; Chamie, Karim; Belldegrun, Arie S.; Pantuck, Allan J.... Journal: Journal of immunotherapy Issue: Volume 43:Issue 9(2020:Nov./Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗